37957344|t|SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy.
37957344|a|Beyond motor neuron degeneration, homozygous mutations in the survival motor neuron 1 (SMN1) gene cause multiorgan and metabolic defects in patients with spinal muscular atrophy (SMA). However, the precise biochemical features of these alterations and the age of onset in the brain and peripheral organs remain unclear. Using untargeted NMR-based metabolomics in SMA mice, we identify cerebral and hepatic abnormalities related to energy homeostasis pathways and amino acid metabolism, emerging already at postnatal day 3 (P3) in the liver. Through HPLC, we find that SMN deficiency induces a drop in cerebral norepinephrine levels in overt symptomatic SMA mice at P11, affecting the mRNA and protein expression of key genes regulating monoamine metabolism, including aromatic L-amino acid decarboxylase (AADC), dopamine beta-hydroxylase (DbetaH) and monoamine oxidase A (MAO-A). In support of the translational value of our preclinical observations, we also discovered that SMN upregulation increases cerebrospinal fluid norepinephrine concentration in Nusinersen-treated SMA1 patients. Our findings highlight a previously unrecognized harmful influence of low SMN levels on the expression of critical enzymes involved in monoamine metabolism, suggesting that SMN-inducing therapies may modulate catecholamine neurotransmission. These results may also be relevant for setting therapeutic approaches to counteract peripheral metabolic defects in SMA.
37957344	0	14	SMN deficiency	Disease	MESH:D007153
37957344	24	50	monoamine neurotransmitter	Chemical	-
37957344	65	88	spinal muscular atrophy	Disease	MESH:D009134
37957344	97	122	motor neuron degeneration	Disease	MESH:D009410
37957344	152	175	survival motor neuron 1	Gene	6606
37957344	177	181	SMN1	Gene	6606
37957344	194	226	multiorgan and metabolic defects	Disease	MESH:D024821
37957344	244	267	spinal muscular atrophy	Disease	MESH:D009134
37957344	269	272	SMA	Disease	MESH:D009134
37957344	453	456	SMA	Disease	MESH:D009134
37957344	475	509	cerebral and hepatic abnormalities	Disease	MESH:D056486
37957344	658	672	SMN deficiency	Disease	MESH:D007153
37957344	700	714	norepinephrine	Chemical	MESH:D009638
37957344	743	746	SMA	Disease	MESH:D009134
37957344	826	835	monoamine	Chemical	-
37957344	858	893	aromatic L-amino acid decarboxylase	Gene	13195
37957344	895	899	AADC	Gene	13195
37957344	902	927	dopamine beta-hydroxylase	Gene	13166
37957344	929	935	DbetaH	Gene	13166
37957344	941	960	monoamine oxidase A	Gene	4128
37957344	962	967	MAO-A	Gene	4128
37957344	1065	1068	SMN	Gene	6606
37957344	1112	1126	norepinephrine	Chemical	MESH:D009638
37957344	1144	1154	Nusinersen	Chemical	MESH:C000590926
37957344	1163	1167	SMA1	Disease	MESH:D014897
37957344	1252	1255	SMN	Gene	6606
37957344	1313	1322	monoamine	Chemical	-
37957344	1351	1354	SMN	Gene	6606
37957344	1387	1400	catecholamine	Chemical	MESH:D002395
37957344	1536	1539	SMA	Disease	MESH:D009134
37957344	Positive_Correlation	MESH:D009638	6606
37957344	Association	MESH:D009638	MESH:D014897
37957344	Association	MESH:D007153	4128
37957344	Association	MESH:D007153	13195
37957344	Association	MESH:D009134	4128
37957344	Association	MESH:D024821	6606
37957344	Association	MESH:D007153	13166
37957344	Association	MESH:C000590926	6606
37957344	Association	MESH:D002395	6606
37957344	Association	MESH:D009638	MESH:D009134
37957344	Negative_Correlation	MESH:C000590926	MESH:D014897
37957344	Negative_Correlation	MESH:D009638	MESH:D007153
37957344	Association	MESH:D014897	6606
37957344	Association	MESH:D009134	6606

